Symbols

MITO(Delisted)

Stealth Bio·NASDAQ

--(--)

MITO Profile

Stealth Biotherapeutics Corp

mitochondrial dysfunction biotech company

Industry

Established Date

04/03/2006

Listing Date

02/15/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.stealthbt.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

One Nexus way, Camana Bay , Grand Cayman , KY1-9005 Cayman Islands

Business

Provide clinical-stage biotechnology services.

Introduction

Stealth BioTherapeutics Corp, an exempted limited liability company incorporated under the laws of the Cayman Islands on 3 April 2006. The company is a clinical-stage biotechnology company headquartered in the United States, focusing on exploring, developing and commercializing new first-in-class therapies for diseases related to mitochondrial dysfunction.